This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cross Country Healthcare (CCRN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 400.00% and 3.20%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Crocs, IAC/InterActive, Fortinet, Tandem Diabetes and Cross Country
by Zacks Equity Research
Zacks.com featured highlights include: Crocs, IAC/InterActive, Fortinet, Tandem Diabetes and Cross Country
Is Cross Country Healthcare (CCRN) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Is (CCRN) Outperforming Other Business Services Stocks This Year?
5 Top-Ranked Stocks Primed for an Earnings Beat
by Sanghamitra Saha
Inside the top-ranked stocks that can beat earnings estimates in their next releases.
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Everi, SPS and Viad
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Everi, SPS and Viad
Robust Jobs Data Paint a Pretty Picture for These Stocks
by Tirthankar Chakraborty
We highlight stocks that can make the most of the underlying strength in the labor market.
Cross Country Healthcare (CCRN) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 200.00% and 1.64%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Cross Country Healthcare (CCRN) Beat on Q2 Earnings?
by Zacks Equity Research
Cross Country Healthcare's (CCRN) second-quarter 2019 results to reflect lower volumes across all three segments.
Earnings Preview: Cross Country Healthcare (CCRN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Cross Country, Kelly Services, Howard, Meridian and American International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cross Country, Kelly Services, Howard, Meridian and American International.
Cross Country (CCRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Cross Country (CCRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
U.S. Jobs Growth Roars Back: Winners & Losers
by Tirthankar Chakraborty
The U.S. economy added more jobs in June than it has in any month this year, which in turn dampened Fed rate cut expectations. In this scenario, let us take a look at the big winners and losers.
Earnings Preview: Cross Country Healthcare (CCRN) Q1 Earnings Expected to Decline
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for April 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for April 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for April 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for March 25th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Earnings Preview: Cross Country Healthcare (CCRN) Q4 Earnings Expected to Decline
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cross Country Healthcare (CCRN) Q3 Earnings Miss Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of -33.33% and 0.10%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare (CCRN) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cross Country Healthcare (CCRN) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of -16.67% and -2.09%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare (CCRN): Moving Average Crossover Alert
by Zacks Equity Research
Cross Country Healthcare, Inc. (CCRN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
What Falling Estimates & Price Mean for Cross Country Healthcare (CCRN)
by Zacks Equity Research
Cross Country Healthcare (CCRN) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.